Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-033714
Filing Date
2015-02-04
Accepted
2015-02-04 16:21:19
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d851247d10q.htm 10-Q 468439
2 EX-31.1 d851247dex311.htm EX-31.1 7439
3 EX-31.2 d851247dex312.htm EX-31.2 7475
4 EX-32.1 d851247dex321.htm EX-32.1 4709
  Complete submission text file 0001193125-15-033714.txt   4281461

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT immu-20141231.xml EX-101.INS 570873
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20141231.xsd EX-101.SCH 39474
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immu-20141231_cal.xml EX-101.CAL 55515
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immu-20141231_def.xml EX-101.DEF 116919
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20141231_lab.xml EX-101.LAB 324819
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20141231_pre.xml EX-101.PRE 225526
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 15575753
SIC: 2835 In Vitro & In Vivo Diagnostic Substances